Yassin, Muhammad
Aqaqe, Nasma
Yassin, Abed Alkader
van Galen, Peter
Kugler, Eitan
Bernstein, Bradley E.
Koren-Michowitz, Maya http://orcid.org/0000-0002-7223-328X
Canaani, Jonathan
Nagler, Arnon
Lechman, Eric R.
Dick, John E.
Wienholds, Erno
Izraeli, Shai
Milyavsky, Michael http://orcid.org/0000-0002-5083-0809
Funding for this research was provided by:
Council for Higher Education
Ministry of Science and Technology, Israel
Israel Science Foundation (ISF 1512/14)
Israel Cancer Research Fund (RCDA 14-171)
Article History
Received: 15 September 2018
Revised: 2 December 2018
Accepted: 20 December 2018
First Online: 31 January 2019
Compliance with ethical standards
:
: BEB owns equity in Fulcrum Therapeutics, 1CellBio Inc, Nohla Therapeutics and HiFiBio Inc., and is an advisor for Fulcrum Therapeutics, HiFiBio Inc and Cell Signaling Technologies.The remaining authors declare that they have no conflict of interest.